Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 173   

Articles published

GSK 1,414.00 +16.00 (1.14%)
price chart
Morning Buzz: GlaxoSmithKline plc (ADR) (NYSE:GSK), Sunedison Inc (NYSE ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) reported Q3 earnings in which sales fell 10% but EPS exceeded estimates, and announced a cost savings plan, as revenues from its flagship respiratory drug Advair continued an extended decline.
Related articles »  
Can Dividend Stock GlaxoSmithKline plc Bounce Back?
Given the widespread nature of this problem, Western authorities have taken a keen interest in the activities of their biopharmaceutical companies both abroad and at home.
Related articles »  
Better Dividend Stock: GlaxoSmithKline PLC or AstraZeneca PLC?
Today we're going to do just that with two of the U.K.'s most enticing dividend stocks: GlaxoSmithKline (NYSE: GSK ) and AstraZeneca (NYSE: AZN ) . By pitting these two against one another in the three key categories, we should be able to determine ...
Related articles »  
Ebola Softens In Liberia
GlaxoSmithKline plc (ADR) (GSK), NewLink Genetics Corp (NLNK), and Johnson & Johnson (JNJ) are topping the list of companies developing Ebola vaccines.
Related articles »  
GlaxoSmithKline PLC
GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products...more.
Stock Update: GlaxoSmithKline plc (ADR) (NYSE:GSK)
[Bloomberg] GlaxoSmithKline plc (ADR) (NYSE:GSK) is exploring an initial public offering for its Viiv Healthcare Ltd. subsidiary to capitalize on the unit's soaring sales of HIV drugs even as revenue for the parent company declines.
Drug Makers Face Difficulties In Developing Ebola Vaccines
The filling of the vials must be done in a BSL2 facility, which only a handful of companies such as GlaxoSmithKline plc (ADR) (GSK), Merck & Co.
GlaxoSmithKline plc (ADR) (NYSE:GSK) Buys Stake in Aspen Pharmacare's ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) the U.K.'s biggest drugmaker, will take a stake in the Japanese subsidiary of Aspen Pharmacare Holdings Ltd.
GlaxoSmithKline plc's "Neutral" Rating Reiterated at JPMorgan ...  Watch List News (press release)
Related articles »  
Jefferies Group Trims GlaxoSmithKline plc Target Price to GBX 1350 (GSK)
GlaxoSmithKline plc logo Research analysts at Jefferies Group decreased their price target on shares of GlaxoSmithKline plc (LON:GSK) from GBX 1,400 ($22.53) to GBX 1,350 ($21.72) in a report released on Tuesday. The firm currently has a �hold� rating ...
GlaxoSmithKline plc Price Target Cut to GBX 1350 by Analysts at Jefferies ...  Mideast Time
GlaxoSmithKline plc Upgraded at Barclays (GSK)  Watch List News (press release)
Related articles »  
GlaxoSmithKline plc Rating Increased to Overweight at Barclays (GSK)
Barclays upgraded shares of GlaxoSmithKline plc (LON:GSK) to an overweight rating in a report issued on Thursday. They currently have GBX 1,600 ($25.74) target price on the stock.